These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 11120482)
21. Topical azathioprine in the treatment of immune-mediated chronic oral inflammatory conditions: a series of cases. Epstein JB; Gorsky M; Epstein MS; Nantel S Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Jan; 91(1):56-61. PubMed ID: 11174572 [TBL] [Abstract][Full Text] [Related]
22. Development and validation of a Patient-Reported Oral Mucositis Symptom (PROMS) scale. Kushner JA; Lawrence HP; Shoval I; Kiss TL; Devins GM; Lee L; Tenenbaum HC J Can Dent Assoc; 2008 Feb; 74(1):59. PubMed ID: 18298885 [TBL] [Abstract][Full Text] [Related]
23. Clinical assessment scale for the rating of oral mucosal changes associated with bone marrow transplantation. Development of an oral mucositis index. Schubert MM; Williams BE; Lloid ME; Donaldson G; Chapko MK Cancer; 1992 May; 69(10):2469-77. PubMed ID: 1568168 [TBL] [Abstract][Full Text] [Related]
24. Therapeutic use of chlorhexidine in bone marrow transplant patients: case studies. Ferretti GA; Hansen IA; Whittenburg K; Brown AT; Lillich TT; Ash RC Oral Surg Oral Med Oral Pathol; 1987 Jun; 63(6):683-7. PubMed ID: 3295655 [TBL] [Abstract][Full Text] [Related]
25. Control of oral mucositis and candidiasis in marrow transplantation: a prospective, double-blind trial of chlorhexidine digluconate oral rinse. Ferretti GA; Ash RC; Brown AT; Parr MD; Romond EH; Lillich TT Bone Marrow Transplant; 1988 Sep; 3(5):483-93. PubMed ID: 3056555 [TBL] [Abstract][Full Text] [Related]
27. Cryotherapy effect on oral mucositis severity among recipients of bone marrow transplantation: a literature review. Tayyem AQ Clin J Oncol Nurs; 2014 Aug; 18(4):E84-7. PubMed ID: 25095309 [TBL] [Abstract][Full Text] [Related]
28. Patient reports of complications of bone marrow transplantation. Bellm LA; Epstein JB; Rose-Ped A; Martin P; Fuchs HJ Support Care Cancer; 2000 Jan; 8(1):33-9. PubMed ID: 10650895 [TBL] [Abstract][Full Text] [Related]
29. Efficiency of supersaturated calcium phosphate mouth rinse treatment in patients receiving high-dose melphalan or BEAM prior to autologous blood stem cell transplantation: a single-center experience. Waśko-Grabowska A; Rzepecki P; Oborska S; Barzał J; Gawroński K; Młot B; Szczylik C Transplant Proc; 2011 Oct; 43(8):3111-3. PubMed ID: 21996239 [TBL] [Abstract][Full Text] [Related]
31. Management of mucositis in bone marrow transplant patients. da Fonseca MA J Dent Hyg; 1999; 73(1):17-21. PubMed ID: 10634117 [TBL] [Abstract][Full Text] [Related]
32. Doxepin rinse for management of mucositis pain in patients with cancer: one week follow-up of topical therapy. Epstein JB; Epstein JD; Epstein MS; Oien H; Truelove EL Spec Care Dentist; 2008; 28(2):73-7. PubMed ID: 18402621 [TBL] [Abstract][Full Text] [Related]
33. A new topical vasoconstrictor-based strategy for prevention of oral mucositis. Soref CM; Fahl WE Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Apr; 117(4):454-61. PubMed ID: 24485785 [TBL] [Abstract][Full Text] [Related]
34. A longitudinal study of oral ulcerative mucositis in bone marrow transplant recipients. Woo SB; Sonis ST; Monopoli MM; Sonis AL Cancer; 1993 Sep; 72(5):1612-7. PubMed ID: 8348492 [TBL] [Abstract][Full Text] [Related]
35. Phase I study of transforming growth factor-beta3 mouthwashes for prevention of chemotherapy-induced mucositis. Wymenga AN; van der Graaf WT; Hofstra LS; Spijkervet FK; Timens W; Timmer-Bosscha H; Sluiter WJ; van Buuren AH; Mulder NH; de Vries EG Clin Cancer Res; 1999 Jun; 5(6):1363-8. PubMed ID: 10389920 [TBL] [Abstract][Full Text] [Related]
36. Prevention of oral mucositis or oral candidiasis for patients with cancer receiving chemotherapy (excluding head and neck cancer). Clarkson JE; Worthington HV; Eden OB Cochrane Database Syst Rev; 2000; (2):CD000978. PubMed ID: 10796567 [TBL] [Abstract][Full Text] [Related]
37. Usefulness and safety of oral cryotherapy in the prevention of oral mucositis after conditioning regimens with high-dose melphalan for autologous stem cell transplantation for lymphoma and myeloma. Batlle M; Morgades M; Vives S; Ferrà C; Oriol A; Sancho JM; Xicoy B; Moreno M; Magallón L; Ribera JM Eur J Haematol; 2014 Dec; 93(6):487-91. PubMed ID: 24889275 [TBL] [Abstract][Full Text] [Related]
38. NASA light-emitting diodes for the prevention of oral mucositis in pediatric bone marrow transplant patients. Whelan HT; Connelly JF; Hodgson BD; Barbeau L; Post AC; Bullard G; Buchmann EV; Kane M; Whelan NT; Warwick A; Margolis D J Clin Laser Med Surg; 2002 Dec; 20(6):319-24. PubMed ID: 12513918 [TBL] [Abstract][Full Text] [Related]
39. Oral complications of local and systemic cancer treatment. Carl W Curr Opin Oncol; 1995 Jul; 7(4):320-4. PubMed ID: 7578379 [TBL] [Abstract][Full Text] [Related]
40. A Phase IIb, Multicenter, Open-Label, Safety, and Efficacy Study of High-Dose, Propylene Glycol-Free Melphalan Hydrochloride for Injection (EVOMELA) for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation. Hari P; Aljitawi OS; Arce-Lara C; Nath R; Callander N; Bhat G; Allen LF; Stockerl-Goldstein K Biol Blood Marrow Transplant; 2015 Dec; 21(12):2100-2105. PubMed ID: 26327631 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]